Dermatol. praxi. 2013;7(4):160-164 [Prakt. lékáren. 2013; 9(6): 225-229]

Systemic treatment of psoriasis

MUDr.Zuzana Nevoralová, Ph.D.
Kožní oddělení nemocnice v Jihlavě

Psoriasis is a chronic, inflammatory hyperproliferative disease of the skin, scalp, nails and joints. It belongs to a group of papulosquamosus

skin disorders and is presented by a variety of clinical presentations. Basic treatment is a local therapy. Another treatment option is

a phototherapy, first of all PUVA and 311 nm methods. Systemic treatment is reserved for severe cases refractery to standard local therapy

and phototherapy and for inicially very severy cases. There are three therapeutics for first line of systemic treatment: acitretin, cyclosporin

A and methotrexat. The second line systemic medicaments are biologics; adalimumab, etanercept, infliximab and ustekinumab

are registered by now. Many completely new therapeutics are developed and proved. Except the treatment a follow-up of a good way

of living, in some cases even a psychotherapy are needed.

Keywords: psoriasis, phototherapy, systemic treatment, biologics

Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nevoralová Z. Systemic treatment of psoriasis. Dermatol. praxi. 2013;7(4):160-164.
Download citation

References

  1. Benáková N. Terapie obecně. In: Benáková N, Ettler K, Štork J, Vašků V. Psoriáza nejen pro praxi. Praha/Kroměříž: Triton 2007: 59-69.
  2. Ettler K. Fototerapie. In: Benáková N, Ettler K, Štork J, Vašků V. Psoriáza nejen pro praxi. Praha/Kroměříž: Triton 2007: 102-112. Fototerapie
  3. Archier E, Devaux S, Castela E, et al. Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012; 26(Suppl. 3): 11-21. Go to original source... Go to PubMed...
  4. Benáková N. Celková terapie. In: Benáková N.: Terapie obecně. In: Benáková N, Ettler K, Štork J, Vašků V. Psoriáza nejen pro praxi. Praha/Kroměříž: Triton 2007: 117-131, 148-152.
  5. Pathriana D, Ormerod AD, Saiag P, et al. European S3-Guidelines on the systemic treatment of psoriasis. J Eur Acad Dermatol Venereol 2009; 23(Suppl. 2): 23, 27. Go to original source... Go to PubMed...
  6. Berend MAM, Sadek J, Kerkhof van de PCM, et al. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent. Dermatol Therapy 2006. Go to original source...
  7. Dostál C, Pavelka K, Saudek F, et al. Ciclosporinum. Remedia 2005; 1: 33-52.
  8. Benáková N, Štork J, et al. Léčba psoriázy biologiky. Konsenzuální doporučené postupy České dermatovenerologické společnosti ČLS JEP 2006. Čes-slov Derm 2006; 81(4): 1-11.
  9. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for management of psoriasis and psoriasis arthritis. Section 6. Guidelines of care for management of psoriasis and psoriasis arthritis: Case-based presentations and evidence-based conclusions. J Am Acad Dermatol 2011; 65: 134-174. Go to original source... Go to PubMed...
  10. Nast A, Boehncke WH, Mrowietz U, et al. S3-Guidelines on the treatment of psoriasis vulgaris. Update 2001. JDDG 2011; 9(Suppl. 2): S1-S95. Go to original source...
  11. Cetkovská P, Kojanová M. Česká doporučení k biologické léčbě závažné chronické ložiskové psoriázy. Čes-slov Derm 2012, 87(1): I-XXII.
  12. Chiricozzi A, Chimenti S. Effective Topical Agents and Emerging Perspectives in the Treatment of Psoriasis. Expert Rev Dermatol 2012; 7(3): 283-293. Go to original source...
  13. Murray PJ. The JAK-STAT signaling pathway: input and output integration. J. Immunol 2007; 178(5): 2623-2629. Go to original source... Go to PubMed...
  14. Subramaniam SV, Cooper RS, Adunyah SE. Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. Biochem Biophys Res Commun 1999; 262(1): 14-19. Go to original source... Go to PubMed...
  15. Kwatra SG, Dabade TS, Gustafson CJ, et al. JAK inhibitors in psoriasis: a promising new treatment modality. J Drugs Dermatol 2012; 11(8): 913-918. Go to PubMed...
  16. Psoriasis Treatment: What´s in the Future? www.webmd. com/skin.
  17. Papp KA, Gulliver W, Lynde CH W, et al. The Future of Psoriasis care. In: Papp KA, Gulliver W, Lynde CH W, et al. Canadian Guidelines for the Management of Plaque Psoriasis. 2009; 1st edn, 89-92.
  18. Pánková R. Psychoterapie v ambulantní praxi. Lékařské listy 2003; 17: 14-16.
  19. Benáková N. Psoriáza v otázkách a odpovědích. Praha: Triton 2005: 128.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.